Results 241 to 250 of about 67,365 (299)

Glucagon-like peptide-1 receptor agonists (GLP-1RA) for neuroprotection following aneurysmal subarachnoid haemorrhage (aSAH): a scoping review

Matt Thomas, Svetlana Mastitskaya, Samuel Parker, Ruth Cookson, Lucy Holmes, Aidan Marsh, Aravind Ramesh, Sarah Rudd, Mario Teo, Alex Mortimer   +9 more
openalex   +1 more source

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

Diabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo, Bianca Aparecida Siqueira, Luiz Felipe Azevedo Marques, Lucas Silva Mello, Fernando Augusto Lima Marson   +4 more
wiley   +1 more source

Co-prescription of metformin and glucagon-like peptide-1 receptor agonists and metformin-associated lactic acidosis: A case series. [PDF]

Clin Nephrol Case Stud
Hussain H, Ali M, Lorlowhakarn K, Capistrano MC, Balakrishnan VS, Jaber BL.   +5 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists in psoriasis and psoriatic arthritis: emerging evidence and future research opportunities. [PDF]

Front Immunol
Ciancio G, Maranini B, Sandri G, Amati G, Bortoluzzi A, Silvagni E, Govoni M, Giuggioli D.   +7 more
europepmc   +1 more source

Association Between Glucagon-Like Peptide-1 Receptor Agonists and Clinical Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Obesity. [PDF]

Drug Des Devel Ther
Huang SC, Wu JY, Kuo CY, Hsu WH, Tsai YW, Lai CC.   +5 more
europepmc   +1 more source

Effects of lifestyle and glucagon-like Peptide-1 receptor agonist-based therapies on waist circumference: A systematic review and meta-analysis

S. GHOSAL, A. Ghosal
openalex   +1 more source

Glucagon-like peptide-1 receptor agonists in movement disorders: From Parkinson's disease to the broader spectrum - Mechanisms, evidence, and future directions. [PDF]

Clin Park Relat Disord
Dahshan A, Khalil MIM, El-Jaafary SI, Al Yamani A.   +3 more
europepmc   +1 more source

Comparison of Perioperative Glycemic Control in Patients Continuing Versus Temporarily Holding Glucagon-Like Peptide-1 Receptor Agonists or Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists Preoperatively. [PDF]

AACE Endocrinol Diabetes
Trykall CC, Hill SB, James AM, Bagnola AJ, Wyne KL, Handley D, Brower KI.   +6 more
europepmc   +1 more source

Interactions of a Glucagon-like peptide 1 and a Glucagon-like peptide 1 analogue, liraglutide, with the endogenous receptor

, 2015
Frederiksen, Tine Maja; id_orcid 0000-0003-2566-8448, Harris, Pernille, Bukrinski, Jens T., Peters, Günther H.J.; id_orcid 0000-0001-9754-2663   +3 more
openaire   +1 more source